<DOC>
	<DOCNO>NCT01895244</DOCNO>
	<brief_summary>Autologous stem cell therapy show effective patient systemic sclerosis . Nevertheless treatment associate treatment related mortality patient die follow despite successful transplantation . Intention trial improve overall survival modify exist protocol use ASTIS trial . To reduce treatment toxicity reduce dose Cyclophosphamide ( CYC ) mobilisation 2x1g . Especially patient cardiac manifestation also modify condition regimen add thiotepa reduce CYC ; CYC know cardiotoxic side effect .</brief_summary>
	<brief_title>Autologous Stem Cell Transplantation Progressive Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<criteria>Diagnosis progressive systemic sclerosis &lt; 7 year Progressive course despite cyclophosphamide pretreatment Cyclophosphamide i.v . : least 3 x 5001000 mg/m² every 34 week Cyclophosphamide p.o . least 100mg/day least 2 month Contraindication treatment cyclophosphamide Progress define least one follow criterion : Increase mRSS Worsening lung function Increase fibrosis/alveolitis thorax CT Worsening kidney function manifestation systemic sclerosis Limited diffuse cutaneous progressive form Ssc organ manifestation lungs/heart kidney Age &lt; 18 year Pregnancy inadequate contraception Severe heart failure ejection fraction ( EF ) &lt; 30 % echo Pulmonary arterial hypertension systolic pulmonary arterial pressure ( PAPsys ) &gt; 50mm Hg Kidney insufficiency : creatinine clearance &lt; 30 ml/min Reduced lung function Inspiratory vital capacity ( IVC ) &lt; 50 % normal Carbon monoxide ( CO ) Diffusion capacity SB &lt; 40 % Previously damage bone marrow Leukopenia &lt; 2,000/µl Thrombopenia &lt; 100,000/µl Previous myelotoxic treatment : Cyclophosphamide &gt; 50g cumulative ( relative ) Infection ( Hepatitis B/C , HIV , Salmonella carrier , syphilis , relative : history tuberculosis ) Severe concomitant psychiatric illness ( depression , psychosis ) Substance dependence Continued nicotine abuse Continued alcohol abuse Continued drug abuse Consent give Poor compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>autologous stem cell transplantation</keyword>
	<keyword>thiotepa</keyword>
	<keyword>cluster differentiation ( CD ) 34 selection</keyword>
</DOC>